medigraphic.com
ISSN 1527-3172 (Electronic)

2008, Number 1

<< Back Next >>

MEDICC Review 2008; 10 (1)

Epidemiology of prenatal genetic and environmental factors of mental retardation in Cuba

Lantigua CA, Portuondo SM, Collazo MT, Lardoeyt FR

Language: English
References: 36
Page: 29-36
PDF size: 276.74 Kb.


ABSTRACT

Introduction One of the most sensitive disabilities in human beings is intellectual disability. In April, 2003, a 10-month study was completed of all persons in Cuba with mental retardation (MR), producing results that included epidemiological variables on a national scale.
Objective Through follow-up research, this paper describes and analyzes 4 prenatal factors associated with MR: Down syndrome (DS), fragile X syndrome (FXS), consanguinity, and maternal alcohol use during pregnancy, in order to provide recommendations for health system decision-makers on consolidating prevention strategies at the community level and improving individual attention to persons with MR.
Materials & Methods All studies were carried out on the basis of strict ethical principles. Data for the 4 prenatal factors was gleaned from the national study’s database. Additional data on affected individuals was obtained through home visits. A previously developed screening instrument was used for clinical genetic analysis to classify possible MR causal factors as prenatal, perinatal, postnatal, psychosis, and unclassifiable. Prenatal included causal factors such as: genetic (by clinical genetic examination, metabolic screening in urine, and routine karyotypes); nonspecific (evidence of prenatal causal factor without diagnosis of genetic or environmental etiology); and environmental (prenatal medical history of biological, physical, or chemical teratogens, endocrine-metabolic diseases, or other maternal diseases known to affect fetal neurodevelopment). Frequency, prevalence, and percentages were reported using a descriptive statistical method. Impact of interventions and actions over time were also compared.
Results MR prevalence in Cuba is 1.25%, lower than the value of 2%-3% reported in developed countries. National prevalence of DS was found to be 4.3 per 10,000 population, representing 22.1% of persons with MR attributed to an ascertained genetic cause. FXS prevalence in a population of individuals of both sexes with MR, initially classified as nonspecific prenatal, psychosis, and unclassifiable, was 2.5 per 1,000 of that population; however, in males of the same population, prevalence was 3.7 per 1,000. At this first stage, such results indicate that this syndrome contributes biologically to the 1.46:1 male/female ratio among the 140,489 individuals with MR. Maternal alcohol use during pregnancy was found in 4.22% of persons with MR and consanguinity was present in 6.89% of the population with MR (10.9% of persons with mild prenatal MR and 14.2% with severe MR). This national data is subdivided by regions and provinces in this paper.
Conclusions Prevalence of MR in Cuba is lower than reference values for developed countries. Knowledge generated by this study about 4 specific causes of MR constitutes pioneering research in the Cuban context, contributing to the field of medical genetics. The results offer the basis for formulation of new scientific contributions related to MR genetics as well as preventive approaches to such genetic factors as consanguinity and to environmental factors such as maternal alcohol use during pregnancy, which affect or target embryo-fetal development of the nervous system.


REFERENCES

  1. Gustavson KH, Hagberg B, Hagberg G, Sars K. Severe mental retardation in a Swedish county, II. Etiological and pathogenetic aspects of children born 1959-1970. Neuropaediatric 1977;(8):293-304.

  2. Lantigua A, Mora F, Arechaederra M, Rojas I, Morales E, Rodriguez H, Viñas C, Noa CE, Barrios B. Etiological characterization of 512 severely mentally retarded institutionalized patients in Havana. Community Genetics 1999;(2):184-9.

  3. Colectivo de Autores. Por la Vida. La Habana: Casa Editora Abril; 2003.

  4. World Medical Association; Ethical Principles for Medical Research Involving Human Subjects. Tokyo: As amended and clarified; 2004.

  5. UNESCO. Declaración Internacional sobre los datos genéticos humanos. París: 2003.

  6. Torres O. Investigaciones con seres humanos para un mundo mejor. La experiencia de Cuba. In: Keyeux et al, editors. Etica de la investigación en seres humanos y políticas de salud pública. Bogotá: UNESCO y Red Latinoamericana y del Caribe: Universidad Nacional de Colombia; 2006.

  7. Organización Mundial de la Salud; CIE 10. Décima revisión de la clasificación Internacional de las enfermedades. Trastornos mentales y del comportamiento. Ginebra: Organización Mundial de la Salud; 1993.

  8. Willemsen R, Smits A, Mohkamsing S. Rapid antibody test for fragile X syndrome: a validation of the technique. Hum Genet 1997;(99):308-11.

  9. Lardoeyt Ferrer R, Lantigua Cruz A. Experiencias técnicas en el uso de la prueba inmunohistoquímica para el diagnóstico del síndrome frágil X. Rev Cubana Invest Biomed 2004;(23):259-65.

  10. De Vries BB, Mohkamsing S, van den Ouweland AMW, Mol E, Gelsema K, van Rijn M, Tibben A, Halley D, Duivenvoorden HJ, Oostra BA, Niermeijer M. Screening for the fragile X syndrome among the mentally retarded: a clinical study. J Med Genet 1999;(36):467-70.

  11. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1976;(98):503- 17.

  12. Day NI, Richardson GA. Prenatal alcohol exposure: A continuum of effects. Semin Perinatl 1991;(15):271-9.

  13. Colectivo de Autores. Informática médica. Bioestadística. Tomo 2. Capítulo 8. Estadística descriptiva. Editorial Ciencias Médicas, La Habana. 2004; pp 211-305.

  14. Leonard H, Wen X. The epidemiology of mental retardation: Challenges and opportunities in the new millennium. Ment Retard Dev Disabil Res Rev 2002;(8):117-34.

  15. Baird PA, Sadovnick AD. Maternal age-specific rates for Down syndrome: Changes over time. Am J Med Genet. 1988;(29):917-27.

  16. Mikkelsen M, Poulsen H, Nielsen KG. Incidence, survival and mortality in Down syndrome in Denmark. Am J Med Genet. 1990;Suppl 7:75-8.

  17. Bacchichetti C, Lenzine E, Pegorano R. Down syndrome in the Belluno district (Veneto region, northeast Italy): Age distribution and morbidity. Am J Med Genet 1990 Suppl 7:84-6.

  18. Viñas Portilla C, Lantigua Cruz A, Delgado Oceguera E. Down’s syndrome: Cytogenetic characteristics in 142 patients. Rev Cubana Pediatr 1989;(61):36-43.

  19. Penrose LS. A Clinical and Genetic Study of Mental Defects. Vol 229 HMSO, London, 1938.

  20. Anuario Demográfico de Cuba 2001. La Habana: ONE; 2002.

  21. Chelly J, Mandel JL. Monogenic causes of X-linked mental retardation. Nature Rev Genet 2001;(2):669-80.

  22. Ropers HH, Hamel BCJ. X-linked Mental Retardation. Nature Rev Genet 2005;(6):46-57.

  23. Lantigua Cruz A. Síndrome Down vs Síndrome frágil X. Educación 1998;93:19-95.

  24. Lantigua Cruz A. Síndrome Frágil X: Mutaciones Dinámicas y su Repercusión en otras Enfermedades Genéticas. Rev Cubana Pediatr 1997;(69):37-47.

  25. Lantigua Cruz A, Ravelo Amargos I, Halley D. Fragile X syndrome: clinical, cytogenetic and molecular correlation in a family. Rev Cubana Pediatr 1997;(69):118-23.

  26. Beresford RG, Tatlidil C, Riddell DC, Welch JP, Ludman MD, Neuman PE, Gree WL. Absence of fragile X syndrome in Nova Scotia. J Med Genet 2000;(37):77-9.

  27. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Hum Genet 1996;(64):196-7.

  28. Terroba A. Personal communication. 2006.

  29. Buyle S, Reyniers E, Vits L et al. Founder effects in Belgian-Dutch fragile X population. Hum Genet 1993;(92):269-72.

  30. Bittles AH. The role and significance of consanguinity as a demographic variable. Population and Development review 1983;(20):561-83.

  31. Marrero M. Personal communication. 2006.

  32. Serrano L. Personal communication. 2006.

  33. Hafez M, El Tahan H, Awadalla M, El- Khayat H, Abdel-Gafar, Ghoneim M. Consanguineous matings in the Egyptian population. J Med Genet 1983;(20):56-60.

  34. Madhavan T, Naravan J. Consanguinity and mental retardation. J Ment Defic Res 1991;(35):133-9.

  35. Sampson PD, Strissguth AP, Bookstein FL et al. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorders. Teratology 1997; 56:317-26.

  36. Byers PH. 2005 ASHG Presidential Address. If Only We Spoke the Same Language- We Would Have So Much to Discuss. Am J Hum Genet 2006;(78):368-72.




2020     |     www.medigraphic.com